Teijin Limited v. Unimark Remedies Ltd.
1:14-cv-01370
Overview
Parties
Defendant
Unimark Remedies Ltd. Operating Company
Represented By
4 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Counter Defendant
Teijin Pharma Limited NPE (University / Research)
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Teijin Limited NPE (University / Research)
Represented By
7 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Takeda Pharmaceuticals USA Inc. Operating Company
Represented By
5 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | Asserted Patent | View Official Patent → |
| 🇯🇵 Japan | Japan Counterpart | View Official Patent → | |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → |
Teijin Limited v. Macleods Pharmaceuticals Ltd.
Teijin Limited v. Prinston Pharmaceutical Inc.
Teijin Limited v. Roxane Laboratories Inc.
Teijin Limited v. Zydus Pharmaceuticals USA Inc.
Teijin Limited v. Alembic Pharmaceuticals Limited
Teijin Limited v. Dr. Reddy's Laboratories Ltd.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7361676
Solid preparation containing single crystal form
|
Filed: 2003-03-28
Issued: 2008-04-22
|
Expired (Term Ended)
+346d PTA
Expires: 2024-03-08
|
|
|
US8372872
Methods for concomitant treatment of theophylline and febuxostat
|
Filed: 2011-11-14
Issued: 2013-02-12
|
Active (5.0 yrs remaining)
Expires: 2031-11-14
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
High PTA (+346 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
3
Dispositive
0
Granted
0
Denied
0
Pending / Review
1
Motions by Category
Key Dispositive Motions & Rulings